BIODESIX, INC. Basic Shares Outstanding (Weighted Average)
BIODESIX, INC. (BDSX) reported Basic Shares Outstanding (Weighted Average) of 10.30 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-05
- BIODESIX, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 10.30M shares, a 40.41% increase year-over-year.
- BIODESIX, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 9.66M shares, a 32.27% increase year-over-year.
- BIODESIX, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 8.07M shares, a 10.04% increase year-over-year.
- BIODESIX, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 7.50M shares, a 2.53% increase year-over-year.
- BIODESIX, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 7.55M shares, a 16.71% increase from fiscal 2024.
- BIODESIX, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 6.47M shares, a 92.12% decline from fiscal 2023.
- BIODESIX, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 82.11M shares, a 95.03% increase from fiscal 2022.
- BIODESIX, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 42.10M shares, a 53.86% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 10.30M shares 10-Q · filed 2026-08-05 | 9.98M shares 10-Q · filed 2026-08-05 | 9.34M shares derived: average of 3 quarters · filed 2026-08-05 | 8.88M shares derived: average of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | 9.66M shares 10-Q · filed 2026-05-04 | 8.86M shares derived: average of 2 quarters · filed 2026-05-04 | 8.41M shares derived: average of 3 quarters · filed 2026-05-04 | 8.14M shares derived: average of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | 8.07M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 7.79M shares derived: average of 2 quarters · filed 2026-02-26 | 7.63M shares derived: average of 3 quarters · filed 2026-08-05 | 7.55M shares 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | 7.50M shares 10-Q · filed 2025-11-03 | 7.42M shares derived: average of 2 quarters · filed 2026-08-05 | 7.38M shares 10-Q · filed 2025-11-03 | 7.37M shares derived: average of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | 7.33M shares 10-Q · filed 2026-08-05 | 146.66M shares 10-Q · filed 2025-08-07 | 7.32M shares 10-Q · filed 2026-08-05 | 146.33M shares 10-Q · filed 2025-08-07 | 7.32M shares derived: average of 3 quarters · filed 2026-08-05 | 7.32M shares derived: average of 4 quarters · filed 2026-08-05 | ||
| 2025-03-31 | 7.30M shares 10-Q · filed 2026-05-04 | 146.55M shares 10-Q · filed 2025-05-13 | 7.32M shares derived: average of 2 quarters · filed 2026-05-04 | 7.32M shares derived: average of 3 quarters · filed 2026-05-04 | 37.28M shares derived: average of 4 quarters · filed 2026-05-04 | |||
| 2024-12-31 | 7.33M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 7.32M shares derived: average of 2 quarters · filed 2026-02-26 | 47.27M shares derived: average of 3 quarters · filed 2026-02-26 | 6.47M shares 10-K · filed 2026-02-26 | 129.67M shares 10-K · filed 2025-03-03 | |||
| 2024-09-30 | 7.32M shares 10-Q · filed 2025-11-03 | 146.30M shares 10-Q · filed 2024-11-01 | 67.24M shares derived: average of 2 quarters · filed 2025-11-03 | 6.18M shares 10-Q · filed 2025-11-03 | 123.63M shares 10-Q · filed 2024-11-01 | 81.02M shares derived: average of 4 quarters · filed 2025-11-03 | ||
| 2024-06-30 | 127.17M shares 10-Q · filed 2025-08-07 | 112.17M shares 10-Q · filed 2025-08-07 | 105.59M shares derived: average of 3 quarters · filed 2025-08-07 | 99.12M shares derived: average of 4 quarters · filed 2025-08-07 | ||||
| 2024-03-31 | 97.17M shares 10-Q · filed 2025-05-13 | 94.80M shares derived: average of 2 quarters · filed 2025-05-13 | 89.77M shares derived: average of 3 quarters · filed 2025-05-13 | 86.95M shares derived: average of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | 92.44M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | 86.07M shares derived: average of 2 quarters · filed 2025-03-03 | 83.55M shares derived: average of 3 quarters · filed 2025-03-03 | 82.11M shares 10-K · filed 2025-03-03 | ||||
| 2023-09-30 | 79.71M shares 10-Q · filed 2024-11-01 | 79.11M shares derived: average of 2 quarters · filed 2024-11-01 | 78.67M shares 10-Q · filed 2024-11-01 | 73.38M shares derived: average of 4 quarters · filed 2024-11-01 | ||||
| 2023-06-30 | 78.51M shares 10-Q · filed 2024-08-07 | 78.14M shares 10-Q · filed 2024-08-07 | 71.27M shares derived: average of 3 quarters · filed 2024-08-07 | 63.57M shares derived: average of 4 quarters · filed 2024-08-07 | ||||
| 2023-03-31 | 77.77M shares 10-Q · filed 2024-05-08 | 67.66M shares derived: average of 2 quarters · filed 2024-05-08 | 58.59M shares derived: average of 3 quarters · filed 2024-05-08 | 53.75M shares derived: average of 4 quarters · filed 2024-05-08 | ||||
| 2022-12-31 | 57.55M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | 49.00M shares derived: average of 2 quarters · filed 2024-03-01 | 45.75M shares derived: average of 3 quarters · filed 2024-03-01 | 42.10M shares 10-K · filed 2024-03-01 | ||||
| 2022-09-30 | 40.45M shares 10-Q · filed 2023-11-07 | 39.84M shares derived: average of 2 quarters · filed 2023-11-07 | 36.95M shares 10-Q · filed 2023-11-07 | 34.45M shares derived: average of 4 quarters · filed 2023-11-07 | ||||
| 2022-06-30 | 39.24M shares 10-Q · filed 2023-08-07 | 35.18M shares 10-Q · filed 2023-08-07 | 32.46M shares derived: average of 3 quarters · filed 2023-08-07 | 31.35M shares derived: average of 4 quarters · filed 2023-08-07 | ||||
| 2022-03-31 | 31.07M shares 10-Q · filed 2023-05-11 | 29.06M shares derived: average of 2 quarters · filed 2023-05-11 | 28.73M shares derived: average of 3 quarters · filed 2023-05-11 | 22.18M shares derived: average of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | 27.06M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | 27.55M shares derived: average of 2 quarters · filed 2023-03-06 | 19.21M shares derived: average of 3 quarters · filed 2023-03-06 | 27.36M shares 10-K · filed 2023-03-06 | ||||
| 2021-09-30 | 28.05M shares 10-Q · filed 2022-11-03 | 15.29M shares derived: average of 2 quarters · filed 2023-03-06 | 27.47M shares 10-Q · filed 2022-11-03 | |||||
| 2021-06-30 | 2.52M shares 10-K · filed 2023-03-06 | 2.52M shares 10-K · filed 2023-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |